Cat.#: ACPP-1729
| Despition | OCM Human Recombinant |
| SIZE | 2 µg |
| Storage | Lyophilized was stored at -20°C to -80°C, while reconstituted was aliquot and stored at -80°C. Avoid freeze/thaw cycles. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1274 | Visfatin Blocking Peptide (AC1274) | 250 µg | inquiry |
| ACPP-1173 | Recombinant Human alpha Synuclein Protein (AC1173) | 50 µl | inquiry |
| ACPP-1246 | Bestrophin Blocking Peptide (AC1246) | 250 µg | inquiry |
| ACPP-1169 | proBNP Blocking Peptide (AC1169) | 250 µg | inquiry |
| ACPP-1634 | NDK E.Coli (AC1634) | 5 µg | inquiry |
| ACPP-1453 | Human ACOT7 Protein (AC1453) | 5 µg | inquiry |
| ACPP-1688 | Human CDK1 Protein, Sf9 (AC1688) | 2 µg | inquiry |
| ACPP-1095 | Synthetic Nanodisc Human MLC1 Protein (AC1095) | 10 µg | inquiry |
| ACPP-1103 | Rat Leptin Protein (AC1103) | 200 µg | inquiry |
| ACPP-1041 | Recombinant Human Wnt3a Protein (AC1041) | 50 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.